Metrics to compare | QSI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipQSIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.0x | −9.3x | −0.3x | |
PEG Ratio | −0.10 | −0.51 | 0.00 | |
Price/Book | 1.7x | 6.0x | 2.6x | |
Price / LTM Sales | 185.5x | 5.8x | 3.0x | |
Upside (Analyst Target) | 69.1% | 12.5% | 62.1% | |
Fair Value Upside | Unlock | −12.9% | 8.1% | Unlock |
Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer’s protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS. It also provides Platinum analysis software, a cloud-based solution that automates data analysis workflows and visualizes the sequencing results. The company was founded in 2013 and is headquartered in Branford, Connecticut.